Literature DB >> 12850244

Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery.

Yasuhiro Suzuki1, Kazunao Kondo, Yuji Matsumoto, Bing-Qing Zhao, Kenichi Otsuguro, Tetsuya Maeda, Yoshinori Tsukamoto, Tetsumei Urano, Kazuo Umemura.   

Abstract

We have previously demonstrated that natto-extracts containing nattokinase (NK) inactivates plasminogen activator inhibitor type 1 and then potentiates fibrinolytic activity. In the present study, we investigated the effects of dietary supplementation with natto-extracts on neointima formation and on thrombolysis at the site of endothelial injury. Endothelial damage in the rat femoral artery was induced by intravenous injection of rose bengal followed by focal irradiation by transluminal green light. Dietary natto-extracts supplementation containing NK of 50 or 100 CU/body was started 3 weeks before endothelial injury and then continued for another 3 weeks. Intimal thickening in animals given supplementation was significantly (P<0.01) suppressed compared with controls and the intima/media ratio in animals with 50 and 100 CU/body NK and control group was 0.09 +/- 0.03, 0.09 +/- 0.06 and 0.16 +/- 0.12, respectively. Although femoral arteries were reopened both in control animals and those treated with NK within 8 hours after endothelial injury, mural thrombi were histologically observed at the site of endothelial injury. In the control group, the center of vessel lumen was reopened and mural thrombi were attached on the surface of vessel walls. In contrast, in NK-treated groups, thrombi near the vessel wall showed lysis and most of them detached from the surface of vessel walls. In conclusion, dietary natto-extracts supplementation suppressed intimal thickening produced by endothelial injury in rat femoral artery. These effects may partially be attributable to NK, which showed enhanced thrombolysis near the vessel wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850244     DOI: 10.1016/s0024-3205(03)00426-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

1.  Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis.

Authors:  Maqsood M Elahi; Charles H Choi; Subbareddy Konda; Jay G Shake
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

Review 2.  Microbial production of nattokinase: current progress, challenge and prospect.

Authors:  Dongbo Cai; Chengjun Zhu; Shouwen Chen
Journal:  World J Microbiol Biotechnol       Date:  2017-04-04       Impact factor: 3.312

3.  Comparative anti-thrombotic activity and haemorrhagic adverse effect of nattokinase and tissue-type plasminogen activator.

Authors:  Haiyu Guo; Young-Hwan Ban; Yeseul Cha; Eun Suk An; Jieun Choi; Da Woom Seo; Dongsun Park; Ehn-Kyoung Choi; Yun-Bae Kim
Journal:  Food Sci Biotechnol       Date:  2019-05-27       Impact factor: 2.391

4.  Secretory expression of nattokinase from Bacillus subtilis YF38 in Escherichia coli.

Authors:  Xiaobo Liang; Shifang Jia; Yufang Sun; Meiling Chen; Xiuzhu Chen; Jin Zhong; Liandong Huan
Journal:  Mol Biotechnol       Date:  2007-07-17       Impact factor: 2.695

5.  Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation.

Authors:  Ja-Young Jang; Tae-Su Kim; Jingmei Cai; Jihyun Kim; Youngeun Kim; Kyungha Shin; Kwang Sei Kim; Sung Kyeong Park; Sung-Pyo Lee; Ehn-Kyoung Choi; Man Hee Rhee; Yun-Bae Kim
Journal:  Lab Anim Res       Date:  2013-12-20

Review 6.  Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease.

Authors:  Yunqi Weng; Jian Yao; Sawyer Sparks; Kevin Yueju Wang
Journal:  Int J Mol Sci       Date:  2017-02-28       Impact factor: 5.923

7.  Nattospes as Effective and Safe Functional Supplements in Management of Stroke.

Authors:  Phuong T Pham; Bo Han; Ba X Hoang
Journal:  J Med Food       Date:  2020-01-14       Impact factor: 2.786

8.  Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases.

Authors:  Giuseppe Gallelli; Giulio Di Mizio; Caterina Palleria; Antonio Siniscalchi; Paolo Rubino; Lucia Muraca; Erika Cione; Monica Salerno; Giovambattista De Sarro; Luca Gallelli
Journal:  Nutrients       Date:  2021-06-13       Impact factor: 5.717

9.  The Effect of Lactic Acid Bacteria-fermented Soybean Milk Products on Carrageenan-induced Tail Thrombosis in Rats.

Authors:  Seitaro Kamiya; Masayoshi Ogasawara; Masayuki Arakawa; Masayori Hagimori
Journal:  Biosci Microbiota Food Health       Date:  2013-07-25

Review 10.  Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Authors:  Hongjie Chen; Eileen M McGowan; Nina Ren; Sara Lal; Najah Nassif; Fatima Shad-Kaneez; Xianqin Qu; Yiguang Lin
Journal:  Biomark Insights       Date:  2018-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.